NCT03938324Completed
Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions
Source: ClinicalTrials.gov · Last updated 17 Jul 2026
Brief summary (registry, in English)
The purpose of this study is to test the efficacy of a peer support coaching intervention to improve activated chronic illness self-management versus an attention control group in 225 adolescents and young adults with childhood onset chronic conditions.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 222 (actual)
- First submitted
- 2 May 2019
- Start date
- 29 Oct 2019
- Primary completion date
- 19 Jun 2024
- Lead sponsor
- Duke University
- Diseases
- Chronic kidney disease, Lupus (SLE), Cystic fibrosis, Sickle cell disease, Type 1 diabetes, Childhood cancers
- NCT number
- NCT03938324
What you commit to
- Study type: Interventional
- Participants enrolled: 222
- From 29 Oct 2019 to the primary completion date, 19 Jun 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Diagnosed cognitive dysfunction
- Need for English translator
Who the study is looking for
- AYA 16 to 22 years
- Childhood onset chronic condition from 1 of 3 condition categories
- Read and speaks English
- Access to internet via computer or Smart Phone
- Access to telephone (Smart Phone not required as text feature can be accessed via internet)
Age in the registry: 16 years to 22 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Duke University Coordinator of this site? Confirm its status | Durham | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.